Active Targeting Using HER-2-Affibody-Conjugated Nanoparticles Enabled Sensitive and Specific Imaging of Orthotopic HER-2 Positive Ovarian Tumors
Version of Record online: 27 AUG 2013
© 2013 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim
Volume 10, Issue 3, pages 544–555, February 12, 2014
How to Cite
Satpathy, M., Wang, L., Zielinski, R., Qian, W., Lipowska, M., Capala, J., Lee, G. Y., Xu, H., Wang, Y. A., Mao, H. and Yang, L. (2014), Active Targeting Using HER-2-Affibody-Conjugated Nanoparticles Enabled Sensitive and Specific Imaging of Orthotopic HER-2 Positive Ovarian Tumors. Small, 10: 544–555. doi: 10.1002/smll.201301593
- Issue online: 4 FEB 2014
- Version of Record online: 27 AUG 2013
- Manuscript Revised: 13 JUL 2013
- Manuscript Received: 23 MAY 2013
- NIH/NCI. Grant Numbers: R01CA133722, U01CA151810
- Nancy Panoz Endowed Chair Funds
As a service to our authors and readers, this journal provides supporting information supplied by the authors. Such materials are peer reviewed and may be re-organized for online delivery, but are not copy-edited or typeset. Technical support issues arising from supporting information (other than missing files) should be addressed to the authors.
Please note: Wiley Blackwell is not responsible for the content or functionality of any supporting information supplied by the authors. Any queries (other than missing content) should be directed to the corresponding author for the article.